EBF - ADC Training day:Bringing ADC into Practice
EBF - Focus Workshop:Bioanalytical Strategies for Large Molecules in Modern Drug Development: LBA and LC-MS united
General info on the EBF can be found on http://www.europeanbioanalysisforum.eu/
For our 1st Focus Workshop of 2017 dedicated to Bioanalytical Strategies for Large Molecules we are planning to include a training day on another hot topic in drug development: Antibody Drug Conjugates (ADC). Although many of the bioanalytical tools are similar and may blend into the workshop, we see value in providing an ADC training day separate from the main Focus Workshop. In this way both themes will get the audience and detailed discussions we look for.
ADC TRAINING DAY
The aim of the ADC training day is to share best practices on science and bioanalytical strategies related to the drug development of antibody drug conjugates. We plan both presentations and Q&A opportunities in an interactive workshop format.
The aim of the focus workshop is to share current best practices in drug R&D related developing bioanalytical strategies and bioanalysis of large molecules in all phases of drug development. At the workshop, we want to provide the delegates and, in extension, the industry a better understanding into the day-to-day challenges of analyzing large molecules, i.e.
- how can we make optimal use of the bioanalytical toolkit to support the drug development of large molecules?
- when and why do we use LBA, LC-MS or a combination of both technologies throughout the drug development process of large molecules and provide teams relevant data for decision making? or
- what are the points to consider when developing a bioanalytical strategy in different phases of drug development?
We are reaching out with a separate call for speakers.